Blog
RSS FeedPosted by Michael Wonder on 05 May 2016
Request for proposal - supply of anti-vascular endothelial growth factor agents
5 May 2016 - PHARMAC invites proposals for the supply of anti-vascular endothelial growth factor agents in New Zealand. ...
Posted by Michael Wonder on 05 May 2016
Proposal to widen funded access to temozolomide for treatment of neuroendocrine tumours and high grade gliomas
4 May 2016 - As part of PHARMAC’s 2015/16 annual Invitation to Tender, PHARMAC is proposing to widen access to fully-funded ...
Posted by Michael Wonder on 05 May 2016
Proposal to widen access to rituximab to include children with nephrotic syndrome
4 May 2016 - PHARMAC is seeking feedback on a proposal to amend the funding restrictions for rituximab in DHB hospitals. ...
Posted by Michael Wonder on 04 May 2016
'It's a very good start' – funding boost for Pharmac welcomed, but is it enough?
5 May 2016 - A top health expert has praised the Government's multi-million dollar funding boost to its pharmaceutical agency Pharmac, ...
Posted by Michael Wonder on 04 May 2016
Melanoma drug could be funded after boost in funding
4 May 2016 - A new generation melanoma drug is likely to be funded by PHARMAC after a $39 million boost ...
Posted by Michael Wonder on 04 May 2016
$124 million increase over four years for investment in new medicines
4 May 2016 - Medicines New Zealand is pleased that the New Zealand Government has today announced a $124 million increase ...
Posted by Michael Wonder on 04 May 2016
Proposals to list hepatitis C treatments
4 May 2016 - PHARMAC is seeking feedback on two proposals to list two new treatments for hepatitis C. ...
Posted by Michael Wonder on 04 May 2016
PHARMAC announces exciting opportunities for improved health from $39 million budget boost
4 May 2016 - PHARMAC is today opening consultations on seven new treatments across a wide range of health areas, says ...
Posted by Michael Wonder on 04 May 2016
Proposal to list nivolumab (Opdivo) for advanced melanoma
4 May 2016 - New Zealand has a very high incidence of advanced melanoma (metastatic or unresectable Stage III and IV ...
Posted by Michael Wonder on 30 Apr 2016
New Zealand Pharmaceutical Schedule - 1 May 2016 update
1 May 2016 - The May 2016 update to the New Zealand Pharmaceutical Schedule sees the listing of two new medicines. ...
Posted by Michael Wonder on 29 Apr 2016
Breakthrough melanoma drug approved
29 April 2016 - A new breakthrough melanoma drug has been approved for use in New Zealand, but like its rival ...
Posted by Michael Wonder on 27 Apr 2016
Medicines New Zealand has never threatened New Zealand
26 April 2016 - Recent statements in the media misrepresent the Medicines New Zealand position on the Trans-Pacific Partnership and are ...
Posted by Michael Wonder on 26 Apr 2016
TPP: no reason big pharma supply would stop
26 April 2016 - Trade Minister Todd McClay says he sees no reason why big pharmaceutical firms would stop supplying ...
Posted by Michael Wonder on 24 Apr 2016
Outcomes from the PTAC February 2016 meeting
22 April 2016 - The outcomes from the February 2016 PTAC meeting are now available. ...
Posted by Michael Wonder on 22 Apr 2016
Cancer drug saves Masterton war veteran
22 April 2016 - Since recovering from suspected incurable melanoma, 73-year-old Bob 'Bukit' Hill jumped off Auckland's Sky Tower, received his ...